Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

CRISPR/Cas systems show promise for cancer treatment by targeting miRNAs, but delivery and specificity challenges remain.

A new, less toxic and more efficient method to create the anti-baldness compound RU58841 was developed in 2014.

Delta opioid receptors help regulate touch sensation by reducing neurotransmitter release in the spinal cord.

Ritlecitinib is more effective and cost-efficient than baricitinib for severe alopecia areata.

A three-month treatment with a GnRH agonist significantly lowered androgen levels and 5α-reductase activity in men with benign prostatic hyperplasia.

Arteannuin might work against cancer and Alzheimer's by targeting neprilysin.

Oral difelikefalin significantly reduces itch in notalgia paresthetica.

Compound 4 is a promising treatment for hair loss with low toxicity.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

OXTR agonists may promote hair growth and be effective for treating hair loss.

17β-estradiol can reduce inflammation in the skin.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Scientists made two new chemicals that might help treat diseases caused by male hormones.

Pranlukast and mirabegron may work as new diabetes drugs.

Cyproterone acetate and ethinylestradiol effectively reduce hirsutism and acne in women.

Naltrexone did not significantly reduce hair pulling but improved cognitive flexibility.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

Existing drugs, including a blood pressure medication, show promise as new treatments for influenza.

Betulinic acid can help treat hepatitis C by stopping virus replication.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Certain immune cells are more common on the top of the head and might help predict or treat common hair loss.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

Choose treatments for sex offenders based on individual needs, using hormonal and nonhormonal options to reduce sexual drive.

Rats developed lung issues from the drugs, but these cleared quickly after stopping them.

Cortexolone 17a-propionate may be an effective new treatment for hair loss.

Some blood pressure medications are linked to a higher risk of skin cancer.

Cepharanthine has many medicinal uses but needs improvement for better effectiveness.

Thioredoxin reductase 1 does not affect glucocorticoid receptor activity in hair follicle cells.